These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29097023)

  • 1. Vav1: Friend and Foe of Cancer.
    Guo F; Zheng Y
    Trends Cell Biol; 2017 Dec; 27(12):879-880. PubMed ID: 29097023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho guanosine nucleotide exchange factors are not such bad guys after all in cancer
    Robles-Valero J; Lorenzo-Martín LF; Fernández-Pisonero I; Bustelo XR
    Small GTPases; 2020 Jul; 11(4):233-239. PubMed ID: 29313423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.
    Robles-Valero J; Lorenzo-Martín LF; Menacho-Márquez M; Fernández-Pisonero I; Abad A; Camós M; Toribio ML; Espinosa L; Bigas A; Bustelo XR
    Cancer Cell; 2017 Nov; 32(5):608-623.e9. PubMed ID: 29136506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unexpected tumor suppressor role for VAV1
    Bustelo XR; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Robles-Valero J
    Mol Cell Oncol; 2018; 5(3):e1432257. PubMed ID: 30250888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles.
    Cuadrado M; Robles-Valero J
    Biology (Basel); 2021 Sep; 10(9):. PubMed ID: 34571765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell Leukemogenesis.
    Wang Z; Hu Y; Xiao D; Wang J; Liu C; Xu Y; Shi X; Jiang P; Huang L; Li P; Liu H; Qing G
    Clin Cancer Res; 2017 Jul; 23(14):3834-3846. PubMed ID: 28143869
    [No Abstract]   [Full Text] [Related]  

  • 7. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav1 regulates MHCII expression in murine resting and activated B cells.
    Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
    Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remedial strategies in structural proteomics: expression, purification, and crystallization of the Vav1/Rac1 complex.
    Brooun A; Foster SA; Chrencik JE; Chien EY; Kolatkar AR; Streiff M; Ramage P; Widmer H; Weckbecker G; Kuhn P
    Protein Expr Purif; 2007 May; 53(1):51-62. PubMed ID: 17275330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells.
    Prisco A; Vanes L; Ruf S; Trigueros C; Tybulewicz VL
    Immunity; 2005 Sep; 23(3):263-74. PubMed ID: 16169499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
    Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
    Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site.
    Kline JB; Moore DJ; Clevenger CV
    Mol Endocrinol; 2001 May; 15(5):832-41. PubMed ID: 11328862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain.
    Amarasinghe GK; Rosen MK
    Biochemistry; 2005 Nov; 44(46):15257-68. PubMed ID: 16285729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.
    Thompson BJ; Buonamici S; Sulis ML; Palomero T; Vilimas T; Basso G; Ferrando A; Aifantis I
    J Exp Med; 2007 Aug; 204(8):1825-35. PubMed ID: 17646408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vav1 in the lipopolysaccharide-mediated upregulation of inducible nitric oxide synthase production and nuclear factor for interleukin-6 expression activity in murine macrophages.
    Godambe SA; Knapp KM; Meals EA; English BK
    Clin Diagn Lab Immunol; 2004 May; 11(3):525-31. PubMed ID: 15138177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand.
    Wilsbacher JL; Moores SL; Brugge JS
    Cell Commun Signal; 2006 May; 4():5. PubMed ID: 16709244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
    Katzav S
    Oncotarget; 2015 Oct; 6(30):28731-42. PubMed ID: 26353933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
    Shalom B; Farago M; Pikarsky E; Katzav S
    Oncogenesis; 2018 Oct; 7(10):80. PubMed ID: 30297765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.
    Aster JC
    Int J Hematol; 2005 Nov; 82(4):295-301. PubMed ID: 16298817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.